- Home
- CLNN
CLNN
Clene Inc.
as 11-14-2025 3:43pm EST
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | SALT LAKE CITY |
| Market Cap: | 120.6M | IPO Year: | N/A |
| Target Price: | $32.67 | AVG Volume (30 days): | 132.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.29 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.28 - $13.50 | Next Earning Date: | 11-13-2025 |
| Revenue: | $214,000 | Revenue Growth: | -49.17% |
| Revenue Growth (this year): | -31.2% | Revenue Growth (next year): | 1363.77% |
Latest Clene Inc. News
CLNN Breaking Stock News: Dive into CLNN Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
Clene Inc. (CLNN) Reports Q3 Loss, Lags Revenue Estimates
GlobeNewswire
3 days ago
Clene Reports Third Quarter 2025 Financial Results and Recent Operating Highlights
Zacks
5 days ago
Oculis Holding AG (OCS) Reports Q3 Loss, Beats Revenue Estimates
Zacks
10 days ago
C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Beats Revenue Estimates
GlobeNewswire
25 days ago
Presenting on Emerging Growth Conference 87 Day 2 on October 23; Register to live stream
GlobeNewswire
a month ago
Clene to Present at the Emerging Growth Conference
GlobeNewswire
a month ago
Clene to Participate in a Panel Discussion at the Maxim Growth Summit
ACCESS Newswire
5 months ago
Q2 Virtual Investor Summit: Presentations Available Now
Compare CLNN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLNN Clene Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.